Summary by Futu AI
AbbVie Inc. officer, Azita Saleki-Gerhardt, is set to sell 52,870 shares of the company's common stock on February 21, 2024, according to a recent filing. The shares, valued at approximately $9,184,486.84, were acquired on the same date through a stock option exercise as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Saleki-Gerhardt in the past three months.